Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 571 AL 585

Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?

Sala-Jarque J, Zimkowska K, Ávila J, Ferrer I, Del Río JA.

Int J Mol Sci. 2022 Sep 29;23(19):11527. doi: 10.3390/ijms231911527.

Conformational Essentials Responsible for Neurotoxicity of Aβ42 Aggregates Revealed by Antibodies against Oligomeric Aβ42

Song C, Zhang T, Zhang Y.

Molecules. 2022 Oct 10;27(19):6751. doi: 10.3390/molecules27196751.

The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death

Thal DR, Tomé SO.

Brain Res Bull. 2022 Nov;190:204-217. doi: 10.1016/j.brainresbull.2022.10.006. Epub 2022 Oct 13.

Tau interactome and RNA binding proteins in neurodegenerative diseases

Kavanagh T, Halder A, Drummond E.

Mol Neurodegener. 2022 Oct 17;17(1):66. doi: 10.1186/s13024-022-00572-6.

Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapy

Grosjean S, Pachón-Angona I, Dawra M, Refouvelet B, Ismaili L.

Future Med Chem. 2022 Nov;14(21):1583-1606. doi: 10.4155/fmc-2022-0170. Epub 2022 Oct 20.

Aβ Deposits in the Neocortex of Adult and Infant Hypoxic Brains, Including in Cases of COVID-19

Priemer DS, Rhodes CH, Karlovich E, Perl DP, Goldman JE.

J Neuropathol Exp Neurol. 2022 Nov 16;81(12):988-995. doi: 10.1093/jnen/nlac095.

Guanidine-based β amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A review

Gehlot P, Kumar S, Kumar Vyas V, Singh Choudhary B, Sharma M, Malik R.

Bioorg Med Chem. 2022 Nov 15;74:117047. doi: 10.1016/j.bmc.2022.117047. Epub 2022 Oct 8.

Vascular Considerations for Amyloid Immunotherapy

Foley KE, Wilcock DM.

Curr Neurol Neurosci Rep. 2022 Nov;22(11):709-719. doi: 10.1007/s11910-022-01235-1. Epub 2022 Oct 21.

It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?

Jacobs N, Theunissen B.

J Alzheimers Dis. 2022;90(4):1401-1415. doi: 10.3233/JAD-220569.

Disclosing Individual Results in Dementia Research: A Proposed Study Participant's Bill of Rights

Walter S, Taylor A, Tyrone J, Langer S, Pagan JR, Hummel CH, Wheaton BM, Zallen DT, Rosen AC.

J Alzheimers Dis. 2022;90(3):945-952. doi: 10.3233/JAD-220810.

Meta analysis of aerobic exercise improving intelligence and cognitive function in patients with Alzheimer's disease

Zhou XP, Zhang LM, Chen GQ, Wang SW, He JF, Li Z, Zhang BS.

Medicine (Baltimore). 2022 Oct 21;101(42):e31177. doi: 10.1097/MD.0000000000031177.

Effectiveness of Physical Exercise on Alzheimer's disease. A Systematic Review

Cámara-Calmaestra R, Martínez-Amat A, Aibar-Almazán A, Hita-Contreras F, de Miguel Hernando N, Achalandabaso-Ochoa A.

J Prev Alzheimers Dis. 2022;9(4):601-616. doi: 10.14283/jpad.2022.57.

Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid

Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR Jr, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2022;9(4):617-624. doi: 10.14283/jpad.2022.56.

Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults

Silverman MH, Duggan S, Bardelli G, Sadler B, Key C, Medlock M, Reynolds L, Wallner B.

J Prev Alzheimers Dis. 2022;9(4):635-645. doi: 10.14283/jpad.2022.71.

Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression

Moga DC, Abner EL, Schmitt FA, Eckmann L, Huffmyer M, Martinez AI, Beech BF, George R, El Khouli RH, Ali D, Jicha GA.

J Prev Alzheimers Dis. 2022;9(4):646-654. doi: 10.14283/jpad.2022.55.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias